JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Other Net Income (Loss) : ฿0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Other Net Income (Loss)?

JSP Pharmaceutical Manufacturing (Thailand) PCL's Other Net Income (Loss) for the three months ended in Mar. 2024 was ฿0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0.00 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL's quarterly Other Net Income (Loss) increased from Sep. 2023 (฿-0.00 Mil) to Dec. 2023 (฿0.00 Mil) but then declined from Dec. 2023 (฿0.00 Mil) to Mar. 2024 (฿0.00 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL's annual Other Net Income (Loss) increased from Dec. 2021 (฿0.00 Mil) to Dec. 2022 (฿0.00 Mil) and increased from Dec. 2022 (฿0.00 Mil) to Dec. 2023 (฿0.00 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL Other Net Income (Loss) Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Other Net Income (Loss) Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial										-	-	-	-	-

JSP Pharmaceutical Manufacturing (Thailand) PCL Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.00 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120

Website

https://www.jsppharma.com

JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines